Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  HIV Infection

  Free Subscription


Articles published in Vaccine

Retrieve available abstracts of 67 articles:
HTML format
Text format



Single Articles


    September 2017
  1. SUNDARAMURTHI JC, Ashokkumar M, Swaminathan S, Hanna LE, et al
    HLA based selection of epitopes offers a potential window of opportunity for vaccine design against HIV.
    Vaccine. 2017 Sep 6. pii: S0264-410X(17)31168.
    PubMed     Text format     Abstract available


    August 2017
  2. DESHMUKH AA, Cantor SB, Fenwick E, Chiao EY, et al
    Adjuvant HPV vaccination for anal cancer prevention in HIV-positive men who have sex with men: The time is now.
    Vaccine. 2017 Aug 11. pii: S0264-410X(17)31073.
    PubMed     Text format     Abstract available


  3. LI Q, Liu Q, Huang W, Wu J, et al
    An LASV GPC pseudotyped virus based reporter system enables evaluation of vaccines in mice under non-BSL-4 conditions.
    Vaccine. 2017 Aug 7. pii: S0264-410X(17)31037.
    PubMed     Text format     Abstract available


    July 2017
  4. WORLD HEALTH ORGANIZATION
    Measles vaccines: WHO position paper, April 2017 - Recommendations.
    Vaccine. 2017 Jul 28. pii: S0264-410X(17)30974.
    PubMed     Text format     Abstract available


  5. PATEL DP, Treat JR, Castelo-Socio L
    Decreased Hepatitis B vaccine response in pediatric patients with atopic dermatitis, psoriasis, and morphea.
    Vaccine. 2017 Jul 20. pii: S0264-410X(17)30933.
    PubMed     Text format     Abstract available


  6. JALLOW S, Madhi SA, Madimabe R, Sipambo N, et al
    Immunogenicity of 13-valent pneumococcal conjugate vaccine among children with underlying medical conditions.
    Vaccine. 2017 Jul 5. pii: S0264-410X(17)30878.
    PubMed     Text format     Abstract available


    June 2017
  7. LARA AN, Sartori AM, Fonseca MO, Lopes MH, et al
    Long-term protection after hepatitis B vaccination in people living with HIV.
    Vaccine. 2017 Jun 29. pii: S0264-410X(17)30827.
    PubMed     Text format     Abstract available


  8. VENEREO-SANCHEZ A, Simoneau M, Lanthier S, Chahal P, et al
    Process intensification for high yield production of influenza H1N1 Gag virus-like particles using an inducible HEK-293 stable cell line.
    Vaccine. 2017 Jun 22. pii: S0264-410X(17)30801.
    PubMed     Text format     Abstract available


  9. SILVA GP, Santos RS, Pereira-Manfro WF, Ferreira B, et al
    A cross-reacting material CRM197 conjugate vaccine induces diphtheria toxin neutralizing antibody response in children and adolescents infected or not with HIV.
    Vaccine. 2017 Jun 6. pii: S0264-410X(17)30748.
    PubMed     Text format     Abstract available


  10. GENITO CJ, Beck Z, Phares TW, Kalle F, et al
    Liposomes containing monophosphoryl lipid A and QS-21 serve as an effective adjuvant for soluble circumsporozoite protein malaria vaccine FMP013.
    Vaccine. 2017 Jun 5. pii: S0264-410X(17)30729.
    PubMed     Text format     Abstract available


    May 2017
  11. PAINTER JE, DiClemente RJ, Jimenez L, Stuart T, et al
    Exploring evidence for behavioral risk compensation among participants in an HIV vaccine clinical trial.
    Vaccine. 2017 May 19. pii: S0264-410X(17)30632.
    PubMed     Text format     Abstract available


  12. BUCKINGHAM L, Becher J, Voytek CD, Fiore D, et al
    Going social: Success in online recruitment of men who have sex with men for prevention HIV vaccine research.
    Vaccine. 2017 May 16. pii: S0264-410X(17)30587.
    PubMed     Text format     Abstract available


  13. VIRNIK K, Nesti E, Dail C, Hockenbury M, et al
    Expression of complete SIV p27 Gag and HIV gp120 engineered outer domains targeted by broadly neutralizing antibodies in live rubella vectors.
    Vaccine. 2017 May 5. pii: S0264-410X(17)30539.
    PubMed     Text format     Abstract available


  14. BOGGIANO C, Eichelberg K, Ramachandra L, Shea J, et al
    "The Impact of Mycobacterium tuberculosis Immune Evasion on Protective Immunity: Implications for TB Vaccine Design" - Meeting report.
    Vaccine. 2017 May 2. pii: S0264-410X(17)30467.
    PubMed     Text format     Abstract available


    April 2017
  15. HU D, Bowder D, Wei W, Thompson J, et al
    Tryptophan 375 stabilizes the outer-domain core of gp120 for HIV vaccine immunogen design.
    Vaccine. 2017 Apr 28. pii: S0264-410X(17)30546.
    PubMed     Text format     Abstract available


  16. SEREMBA E, Van Geertruyden JP, Ssenyonga R, Opio CK, et al
    Early childhood transmission of hepatitis B prior to the first hepatitis B vaccine dose is rare among babies born to HIV-infected and non-HIV infected mothers in Gulu, Uganda.
    Vaccine. 2017 Apr 20. pii: S0264-410X(17)30484.
    PubMed     Text format     Abstract available


  17. MELNYCHUK L, Ajamian L, Jean-Pierre P, Liang J, et al
    Development of a DNA vaccine expressing a secreted HIV-1 gp41 ectodomain that includes the membrane-proximal external region.
    Vaccine. 2017 Apr 6. pii: S0264-410X(17)30355.
    PubMed     Text format     Abstract available


    March 2017
  18. TANG X, Guo J, Cheng L, Sun C, et al
    Single N277A substitution in C2 of simian immunodeficiency virus envelope influences vaccine-elicited CD4i neutralizing and anti-V2 antibody responses.
    Vaccine. 2017 Mar 30. pii: S0264-410X(17)30389.
    PubMed     Text format     Abstract available


  19. SHI J, Feng Y, Gao L, Feng D, et al
    Immunogenicity and safety of a high-dose hepatitis B vaccine among patients receiving methadone maintenance treatment: A randomized, double-blinded, parallel-controlled trial.
    Vaccine. 2017 Mar 23. pii: S0264-410X(17)30340.
    PubMed     Text format     Abstract available


  20. VAN REGENMORTEL MH
    Immune systems rather than antigenic epitopes elicit and produce protective antibodies against HIV.
    Vaccine. 2017 Mar 17. pii: S0264-410X(17)30323.
    PubMed     Text format    


  21. HUANG X, Zhu Q, Huang X, Yang L, et al
    In vivo electroporation in DNA-VLP prime-boost preferentially enhances HIV-1 envelope-specific IgG2a, neutralizing antibody and CD8 T cell responses.
    Vaccine. 2017 Mar 16. pii: S0264-410X(17)30312.
    PubMed     Text format     Abstract available


  22. SEIB K, Pollard AJ, de Wals P, Andrews RM, et al
    Policy making for vaccine use as a driver of vaccine innovation and development in the developed world.
    Vaccine. 2017;35:1380-1389.
    PubMed     Text format     Abstract available


  23. SETH L, Bingham Ferlez KM, Kaba SA, Musser DM, et al
    Development of a self-assembling protein nanoparticle vaccine targeting Plasmodium falciparum Circumsporozoite Protein delivered in three Army Liposome Formulation adjuvants.
    Vaccine. 2017 Mar 5. pii: S0264-410X(17)30243.
    PubMed     Text format     Abstract available


  24. GIERSING BK, Vekemans J, Nava S, Kaslow DC, et al
    Report from the World Health Organization's third Product Development for Vaccines Advisory Committee (PDVAC) meeting, Geneva, 8-10th June 2016.
    Vaccine. 2017 Mar 2. pii: S0264-410X(16)31205.
    PubMed     Text format     Abstract available


    February 2017
  25. LEVIN MJ, Huang S, Moscicki AB, Song LY, et al
    Four-year persistence of type-specific immunity after quadrivalent human papillomavirus vaccination in HIV-infected children: Effect of a fourth dose of vaccine.
    Vaccine. 2017 Feb 23. pii: S0264-410X(17)30215.
    PubMed     Text format     Abstract available


  26. BALASUBRAMANIAN P, Kumar R, Williams C, Itri V, et al
    Differential induction of anti-V3 crown antibodies with cradle- and ladle-binding modes in response to HIV-1 envelope vaccination.
    Vaccine. 2017 Feb 6. pii: S0264-410X(17)30089.
    PubMed     Text format     Abstract available


    January 2017
  27. HUANG Y, Zhang L, Janes H, Frahm N, et al
    Predictors of durable immune responses six months after the last vaccination in preventive HIV vaccine trials.
    Vaccine. 2017 Jan 25. pii: S0264-410X(16)30879.
    PubMed     Text format     Abstract available


  28. ABARA WE, Collier MG, Teshale EH
    Impact of universal infant hepatitis B vaccination in the US-affiliated Pacific Islands, 1985-2015.
    Vaccine. 2017 Jan 20. pii: S0264-410X(17)30039.
    PubMed     Text format     Abstract available


  29. HOEST C, Seidman JC, Lee G, Platts-Mills JA, et al
    Vaccine coverage and adherence to EPI schedules in eight resource poor settings in the MAL-ED cohort study.
    Vaccine. 2017;35:443-451.
    PubMed     Text format     Abstract available


  30. CHEGE GK, Burgers WA, Muller TL, Gray CM, et al
    DNA-MVA-protein vaccination of rhesus macaques induces HIV-specific immunity in mucosal-associated lymph nodes and functional antibodies.
    Vaccine. 2017 Jan 6. pii: S0264-410X(16)31294.
    PubMed     Text format     Abstract available


  31. BREWER MG, DiPiazza A, Acklin J, Feng C, et al
    Nanoparticles decorated with viral antigens are more immunogenic at low surface density.
    Vaccine. 2017 Jan 3. pii: S0264-410X(16)31274.
    PubMed     Text format     Abstract available


    December 2016
  32. MATTHIESSEN L, Lang H, Klimathianaki M, Hanrahan F, et al
    European strategy for vaccine development against infectious diseases.
    Vaccine. 2016 Dec 22. pii: S0264-410X(16)30952.
    PubMed     Text format     Abstract available


  33. POWELL AM, Luo Z, Martin L, Wan Z, et al
    The induction of CD80 and apoptosis on B cells and CD40L in CD4+ T cells in response to seasonal influenza vaccination distinguishes responders versus non-responders in healthy controls and aviremic ART-treated HIV-infected individuals.
    Vaccine. 2016 Dec 22. pii: S0264-410X(16)31233.
    PubMed     Text format     Abstract available


  34. RUAN S, Cai Y, Ramsay AJ, Welsh DA, et al
    B cell and antibody responses in mice induced by a putative cell surface peptidase of Pneumocystis murina protect against experimental infection.
    Vaccine. 2016 Dec 21. pii: S0264-410X(16)31144.
    PubMed     Text format     Abstract available


  35. MOSERI A, Sinha E, Zommer H, Arshava B, et al
    Immunofocusing using conformationally constrained V3 peptide immunogens improves HIV-1 neutralization.
    Vaccine. 2016 Dec 7. pii: S0264-410X(16)31178.
    PubMed     Text format     Abstract available


    November 2016
  36. POTEET E, Lewis P, Chen C, Ho SO, et al
    Toll-like receptor 3 adjuvant in combination with virus-like particles elicit a humoral response against HIV.
    Vaccine. 2016;34:5886-5894.
    PubMed     Text format     Abstract available


  37. ALLEMAN MM, Wannemuehler KA, Hao L, Perelygina L, et al
    Estimating the burden of rubella virus infection and congenital rubella syndrome through a rubella immunity assessment among pregnant women in the Democratic Republic of the Congo: Potential impact on vaccination policy.
    Vaccine. 2016 Nov 17. pii: S0264-410X(16)30994.
    PubMed     Text format     Abstract available


  38. PEREIRA-MANFRO WF, Alvino RM, Cruz AC, Silva GP, et al
    Association of serum bactericidal antibody and opsonic antibody levels after Neisseria meningitidis serogroup C conjugate vaccine in Brazilian children and adolescents infected or not infected with HIV.
    Vaccine. 2016 Nov 12. pii: S0264-410X(16)31042.
    PubMed     Text format     Abstract available


  39. YU HT, Wang JY, Tian D, Wang MX, et al
    Comparison of the patterns of antibody recall responses to HIV-1 gp120 and hepatitis B surface antigen in immunized mice.
    Vaccine. 2016 Nov 11. pii: S0264-410X(16)30998.
    PubMed     Text format     Abstract available


  40. FONTENOT HB, Fantasia HC, Vetters R, Zimet GD, et al
    Increasing HPV vaccination and eliminating barriers: Recommendations from young men who have sex with men.
    Vaccine. 2016 Nov 9. pii: S0264-410X(16)31026.
    PubMed     Text format     Abstract available


    October 2016
  41. HERTZ T, Logan MG, Rolland M, Magaret CA, et al
    A study of vaccine-induced immune pressure on breakthrough infections in the Phambili phase 2b HIV-1 vaccine efficacy trial.
    Vaccine. 2016 Oct 15. pii: S0264-410X(16)30880.
    PubMed     Text format     Abstract available


  42. BAMFORD A, Manno EC, Mellado MJ, Spoulou V, et al
    Immunisation practices in centres caring for children with perinatally acquired HIV: A call for harmonisation.
    Vaccine. 2016 Oct 7. pii: S0264-410X(16)30848.
    PubMed     Text format     Abstract available


  43. ABADOM TR, Smith AD, Tempia S, Madhi SA, et al
    Risk factors associated with hospitalisation for influenza-associated severe acute respiratory illness in South Africa: A case-population study.
    Vaccine. 2016 Oct 6. pii: S0264-410X(16)30824.
    PubMed     Text format     Abstract available


    September 2016
  44. GIRARD MP, Le-Grand R, Picot V, Longuet C, et al
    Report of the Cent Gardes HIV Vaccines Conference, Part 2: The cellular immune response. Fondation Merieux Conference Center, Veyrier-du-Lac, France, 25-27 October 2015.
    Vaccine. 2016 Sep 27. pii: S0264-410X(16)30847.
    PubMed     Text format    


  45. HOLECHEK SA, McAfee MS, Nieves LM, Guzman VP, et al
    Retinaldehyde dehydrogenase 2 as a molecular adjuvant for enhancement of mucosal immunity during DNA vaccination.
    Vaccine. 2016 Sep 23. pii: S0264-410X(16)30826.
    PubMed     Text format     Abstract available


  46. DZANIBE S, Adrian PV, Kimaro Mlacha SZ, Madhi SA, et al
    Natural acquired group B Streptococcus capsular polysaccharide and surface protein antibodies in HIV-infected and HIV-uninfected children.
    Vaccine. 2016 Sep 20. pii: S0264-410X(16)30828.
    PubMed     Text format     Abstract available


  47. MUNIER CM, van Bockel D, Bailey M, Ip S, et al
    The primary immune response to Vaccinia virus vaccination includes cells with a distinct cytotoxic effector CD4 T-cell phenotype.
    Vaccine. 2016 Sep 14. pii: S0264-410X(16)30805.
    PubMed     Text format     Abstract available


  48. ANDERSSON AC, Ragonnaud E, Seaton KE, Sawant S, et al
    Effect of HIV-1 envelope cytoplasmic tail on adenovirus primed virus encoded virus-like particle immunizations.
    Vaccine. 2016 Sep 12. pii: S0264-410X(16)30798.
    PubMed     Text format     Abstract available


    August 2016
  49. CRUM-CIANFLONE NF, Won S, Lee R, Lalani T, et al
    Vitamin D levels and influenza vaccine immunogenicity among HIV-infected and HIV-uninfected adults.
    Vaccine. 2016 Aug 28. pii: S0264-410X(16)30432.
    PubMed     Text format     Abstract available


  50. PENALOZA-MACMASTER P, Alayo QA, Ra J, Provine NM, et al
    Inhibitory receptor expression on memory CD8 T cells following Ad vector immunization.
    Vaccine. 2016 Aug 24. pii: S0264-410X(16)30733.
    PubMed     Text format     Abstract available


  51. MORO PL, Chen RT
    Obstetrical and neonatal case definitions for immunization safety data.
    Vaccine. 2016 Aug 20. pii: S0264-410X(16)30698.
    PubMed     Text format    


  52. SUMNER RP, Ren H, Ferguson BJ, Smith GL, et al
    Increased attenuation but decreased immunogenicity by deletion of multiple vaccinia virus immunomodulators.
    Vaccine. 2016 Aug 17. pii: S0264-410X(16)30659.
    PubMed     Text format     Abstract available


  53. MONEY DM, Moses E, Blitz S, Vandriel SM, et al
    HIV viral suppression results in higher antibody responses in HIV-positive women vaccinated with the quadrivalent human papillomavirus vaccine.
    Vaccine. 2016 Aug 17. pii: S0264-410X(16)30673.
    PubMed     Text format     Abstract available


  54. WESTMAN ME, Malik R, Hall E, Harris M, et al
    The protective rate of the feline immunodeficiency virus vaccine: An Australian field study.
    Vaccine. 2016 Aug 10. pii: S0264-410X(16)30511.
    PubMed     Text format     Abstract available


  55. LI X, Huang J, Zhang M, Funakoshi R, et al
    Human CD8+ T cells mediate protective immunity induced by a human malaria vaccine in human immune system mice.
    Vaccine. 2016 Aug 5. pii: S0264-410X(16)30663.
    PubMed     Text format     Abstract available


    July 2016
  56. HERATH S, Le Heron A, Colloca S, Patterson S, et al
    Strain-dependent and distinctive T-cell responses to HIV antigens following immunisation of mice with differing chimpanzee adenovirus vaccine vectors.
    Vaccine. 2016 Jul 21. pii: S0264-410X(16)30611.
    PubMed     Text format     Abstract available


  57. CLARKE DK, Hendry RM, Singh V, Rose JK, et al
    Live virus vaccines based on a vesicular stomatitis virus (VSV) backbone: Standardized template with key considerations for a risk/benefit assessment.
    Vaccine. 2016 Jul 6. pii: S0264-410X(16)30548.
    PubMed     Text format     Abstract available


  58. RITZ N, Casalaz D, Donath S, Tebruegge M, et al
    Comparable CD4 and CD8 T cell responses and cytokine release after at-birth and delayed BCG immunisation in infants born in Australia.
    Vaccine. 2016 Jul 5. pii: S0264-410X(16)30557.
    PubMed     Text format     Abstract available


    June 2016
  59. CONDIT RC, Williamson AL, Sheets R, Seligman SJ, et al
    Unique safety issues associated with virus-vectored vaccines: Potential for and theoretical consequences of recombination with wild type virus strains.
    Vaccine. 2016 Jun 23. pii: S0264-410X(16)30225.
    PubMed     Text format     Abstract available


  60. WIYSONGE CS, Waggie Z, Hawkridge A, Schoub BD, et al
    The Cape Town Declaration on Vaccines 2012: Unlocking the full potential of vaccines in Africa.
    Vaccine. 2016 Jun 14. pii: S0264-410X(16)30398.
    PubMed     Text format     Abstract available


  61. ABDULLAHI LH, Kagina BM, Cassidy T, Adebayo EF, et al
    Knowledge, attitudes and practices on adolescent vaccination among adolescents, parents and teachers in Africa: A systematic review.
    Vaccine. 2016 Jun 8. pii: S0264-410X(16)30437.
    PubMed     Text format     Abstract available


    May 2016
  62. GIRARD MP, Le-Grand R, Picot V, Longuet C, et al
    Report of the Cent Gardes HIV Vaccines Conference. Part 1: The antibody response; Fondation Merieux Conference Center, Veyrier-du-Lac, France, 25-27 October 2015.
    Vaccine. 2016 May 20. pii: S0264-410X(16)30314.
    PubMed     Text format     Abstract available


  63. THORNE A, Chowdhury F, Singer J, Keynan Y, et al
    Comparison of hemagglutination inhibition and microbead array assays for the measurement of influenza antibody levels in HIV-infected adults.
    Vaccine. 2016 May 19. pii: S0264-410X(16)30310.
    PubMed     Text format     Abstract available


  64. ZHANG Q, Liu Z, Hou J, Wang S, et al
    Improved safety of a replication-competent poxvirus-based HIV vaccine with the introduction of the HSV-TK/GCV suicide gene system.
    Vaccine. 2016 May 16. pii: S0264-410X(16)30295.
    PubMed     Text format     Abstract available


  65. ASTURIAS EJ, Wharton M, Pless R, MacDonald NE, et al
    Contributions and challenges for worldwide vaccine safety: The Global Advisory Committee on Vaccine Safety at 15 years.
    Vaccine. 2016 May 16. pii: S0264-410X(16)30301.
    PubMed     Text format     Abstract available


  66. VENEREO-SANCHEZ A, Gilbert R, Simoneau M, Caron A, et al
    Hemagglutinin and neuraminidase containing virus-like particles produced in HEK-293 suspension culture: An effective influenza vaccine candidate.
    Vaccine. 2016 May 4. pii: S0264-410X(16)30264.
    PubMed     Text format     Abstract available


  67. ALDHAMEN YA, Rastall DP, Chen W, Seregin SS, et al
    CRACC-targeting Fc-fusion protein induces activation of NK cells and DCs and improves T cell immune responses to antigenic targets.
    Vaccine. 2016 May 3. pii: S0264-410X(16)30233.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: